Monday, January 09, 2023 1:32:34 PM
NWBO has a proven and very safe treatment for the worst cancer out there.
Meanwhile Fauci and the FDA approved the use of Remdesivir to treat covid on the basis of what studies. I was truly shocked to see that this was implemented knowing the terrible side effects including kidney failure in multiple patients when this was first trialed in West Africa, a trial it categorically failed in.
The use of this drug proves the absolute corruption that is in place and even though it was categorically proven to be useless I wonder how many patients died during the use of this treatment along with ventilators.
How long will it take for these regulators to approve DCVAX that has gone through a decade of trials. This is a treatment that has no serious side effects.
I remember when a doctor on this site openly said they were using Remdesivir and it displayed to me the complete lack of research the medical community does when tasked to use a treatment. I wonder how many doctors even bothered to look up the trials for this nasty treatment.
Covid vaccine treatments will fall under the same category and I wonder how many people even bothered to actually research all the past failures of mRNA trials leading to there sudden appearance as the saviour of mankind.
I just hope that the total corruption that seeps through the FDA. BP and big Government does not stop the use of DCVAX as the first truly viable treatment of GBM. All IMHO
To those sceptics on here regarding the role of Remdesivir, here you go.
Remdesivir Falls Flat
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM